Versican can promote tumor cell invasion and metastasis by activating NF-κB signaling and upregulating the hyaluronic acid receptor CD44, receptor for HA mediated motility(RHAMM), and matrix metalloproteinase 9 (MMP9) [29]. The gene discussed is CD44; the disease is neoplasm.